CCL19 suppresses angiogenesis through promoting miR-206 and inhibiting Met/ERK/Elk-1/HIF-1α/VEGF-A pathway in colorectal cancer
2018 · Cell Death and Disease · 178 citations
https://doi.org/10.1038/s41419-018-1010-2
Z
Zhuoqing Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
31
Papers
1.0K
Citations
17
h-index
18
i10-index
Zhuoqing Xu is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Cytokine Signaling Pathways and Interactions & Chemokine receptors and signaling & Cancer Immunotherapy and Biomarkers. The author has an h-index of 17, co-authored 27 publications.
ORCID: 0000-0002-3062-3183Papers by this author
worksIL-17A-mediated mitochondrial dysfunction induces pyroptosis in colorectal cancer cells and promotes CD8 + T-cell tumour infiltration
2023 · Journal of Translational Medicine · 67 citations
https://doi.org/10.1186/s12967-023-04187-3
A positive feedback loop of β-catenin/CCR2 axis promotes regorafenib resistance in colorectal cancer
2019 · Cell Death and Disease · 34 citations
https://doi.org/10.1038/s41419-019-1906-5
VPS35 promotes cell proliferation via EGFR recycling and enhances EGFR inhibitors response in gastric cancer
2023 · EBioMedicine · 26 citations
https://doi.org/10.1016/j.ebiom.2023.104451
Intracorporeal versus extracorporeal anastomosis in laparoscopic right colectomy: a retrospective study
2023 · World Journal of Surgical Oncology · 11 citations
https://doi.org/10.1186/s12957-023-03023-8
Colorectal cancer tissue-originated spheroids reveal tumor intrinsic signaling pathways and mimic patient clinical chemotherapeutic response as a rapid and valid model
2023 · Biomedicine & Pharmacotherapy · 6 citations
https://doi.org/10.1016/j.biopha.2023.115585
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat